Humacyte Inc. (HUMA)
NASDAQ: HUMA
· Real-Time Price · USD
1.81
-0.07 (-3.72%)
At close: Aug 18, 2025, 3:59 PM
1.87
3.31%
Pre-market: Aug 19, 2025, 04:40 AM EDT
-3.72% (1D)
| Bid | 1.81 |
| Market Cap | 286.65M |
| Revenue (ttm) | 7.75M |
| Net Income (ttm) | -77.67M |
| EPS (ttm) | -0.47 |
| PE Ratio (ttm) | -3.85 |
| Forward PE | -9.94 |
| Analyst | Buy |
| Ask | 1.88 |
| Volume | 3,472,056 |
| Avg. Volume (20D) | 4,662,562 |
| Open | 1.89 |
| Previous Close | 1.88 |
| Day's Range | 1.79 - 1.92 |
| 52-Week Range | 1.15 - 7.48 |
| Beta | 1.90 |
About HUMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HUMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HUMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Humacyte Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-29.44%
Humacyte shares are trading lower after the compan...
Unlock content with
Pro Subscription
3 weeks ago
+18.7%
Humacyte shares are trading higher after the company announced the first Symvess sale to a U.S. military treatment facility.
